Jiaji Jiang

Fujian Medical University — China

Medicine · Health Sciences

25h-index2.1kcitations92works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatitis B Virus Studies(65), Hepatitis C virus research(58), Liver Disease Diagnosis and Treatment(54), Liver Disease and Transplantation(7), Hepatitis Viruses Studies and Epidemiology(7)

Publications92 total

Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial
Hepatology International·2025· 4 citedOpen Access
Cumulative Hepatitis B Surface Antigen/Hepatitis B Virus DNA Ratio in Immune-tolerant Hepatitis B Patients: A 10-year Follow-up Study
Journal of Clinical and Translational Hepatology·2025Open Access
SAT-320 Combination therapy of entecavir, peginterferon alpha and granulocyte-macrophage colony stimulating factor enhanced HBsAg loss and HBsAb response
Journal of Hepatology·2025· 1 cited
Determining optimal <scp>ALT</scp> cut‐off values for predicting significant hepatic histological changes in patients with normal <scp>ALT</scp> in the grey zone of chronic hepatitis B virus infection
Alimentary Pharmacology & Therapeutics·2024· 6 citedOpen Access
Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers
Journal of Medical Virology·2023· 3 citedOpen Access
[Short-term efficacy of empagliflozin in children with glycogen storage disease type Ⅰb].
PubMed·2023· 3 cited
Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase
Journal of Clinical and Translational Hepatology·2023· 4 citedOpen Access
Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes
World Journal of Gastroenterology·2022· 13 citedOpen Access
Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores
Journal of Clinical and Translational Hepatology·2022· 10 citedOpen Access
The global disease burden of varicella‐zoster virus infection from 1990 to 2019
Journal of Medical Virology·2021· 48 cited
The Risk of HCC in Patients with Chronic Hepatitis B is Increased by Concomitant Presence of MAFLD but not NAFLD
2021· 2 citedOpen Access
Functional cure based on pegylated interferon alpha in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: A multicenter real-world study (everest project in china), a sequential report the predictors for HBsAg loss
2021
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
Journal of Hepatology·2021· 114 cited
Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection
World Journal of Gastroenterology·2021· 33 citedOpen Access
Combination of NA, PEG-IFN alpha-2b and GM-CSF enhanced hbsab production in NA experienced CHB patients (the anchor a study): an interim analysis
Journal of Hepatology·2020· 4 citedOpen Access
Mechanism of inhibiting proliferation of hepatocellular carcinoma Hepa1‑6 cells by embryonic stem cell‑conditioned medium
Experimental and Therapeutic Medicine·2020Open Access
Modelling and optimization of a modified sequential multilateration method for three-dimensional coordinate collection
Advances in Mechanical Engineering·2019· 6 citedOpen Access
Long-Term Outcomes in Chinese Patients with Chronic Hepatitis B Receiving Nucleoside/Nucleotide Analogue Therapy in Real-World Clinical Practice: 5-Year Results from the EVOLVE Study
Antiviral Therapy·2019· 6 cited
Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure
BioMed Research International·2019· 6 citedOpen Access
Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study
Hepatology International·2019· 48 cited
page 1 of 5Next →

Frequent Co-authors

Yueyong Zhu(25), Da‐Wu Zeng(14), Jing Dong(13), Xiaoguang Dou(12), Qin Ning(9), Jinlin Hou(9), Su Lin(9), Jia Shang(8), Qing Xie(8), Yurui Liu(8), Qi Zheng(8), Yongtao Sun(7), Jianning Jiang(7), Hong Ren(7), Jidong Jia(6), Ming-Fang Wang(6), Yurong Liu(6), Deming Tan(5), Hong Tang(5), Peng Hu(5)